| For: | Tan YW, Chen L, Zhou XB. Efficacy of artificial liver support system in severe immune-associated hepatitis caused by camrelizumab: A case report and review of the literature. World J Clin Cases 2021; 9(17): 4415-4422 [PMID: 34141809 DOI: 10.12998/wjcc.v9.i17.4415] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i17/4415.htm |
| Number | Citing Articles |
| 1 |
Haorui Hu, Xinyi Shen, Jiajia Chen. Advances in mechanistic investigation and treatment of steroid-refractory ICI-induced liver injury. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01721-z
|
| 2 |
Lily Dara, Eleonora De Martin. Immune‐Mediated Liver Injury From Checkpoint Inhibitor: An Evolving Frontier With Emerging Challenges. Liver International 2025; 45(2) doi: 10.1111/liv.16198
|
| 3 |
Kefan Chen, Junhao He, Jing Xu, Jie Chen. Effectiveness of immunosuppressant use for the treatment of immune checkpoint inhibitor-induced liver injury: A systematic review and meta-analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1088741
|
| 4 |
Hui Xing, Yang Wang, Bo Qu, Qiang Wei, Cuihua Li, Chao Pan, Hui Li. The Current status of steroid-refractory immune-checkpoint-inhibitor-related hepatotoxicity. Translational Oncology 2023; 28 doi: 10.1016/j.tranon.2023.101619
|
| 5 |
Yi Huang, Wei Li, Mohammed Misbah Ul Haq. Safety profile of camrelizumab: An analysis based on literature and database review. PLOS One 2026; 21(7) doi: 10.1371/journal.pone.0354252
|
| 6 |
Kai Zhang, Li-Ping Liu, You-Wen Tan. Double plasma molecular adsorption system for Stevens–Johnson syndrome/toxic epidermal necrolysis: A case report. World Journal of Clinical Cases 2024; 12(7): 1371-1377 doi: 10.12998/wjcc.v12.i7.1371
|
| 7 |
Sarita Chonat, Jonathan Soldera. Autoimmune Hepatitis Induced by Immune Checkpoint Inhibitors in Adults: A Systematic Review. Diagnostics 2026; 16(12) doi: 10.3390/diagnostics16121821
|
| 8 |
Qiangfeng Wang, Cheng Xiao, Peipei Hu, Xiuming Zhang, Jiangshan Lian, Xingyun Su, Xiongfei Yu, Jiajia Chen, Yulong Zheng. Artificial liver support systems bridge severe immune-mediated hepatotoxicity to clinical recovery. Immunopharmacology and Immunotoxicology 2025; 47(2) doi: 10.1080/08923973.2025.2454030
|
| 9 |
|
| 10 |
Oluwatoyosi A. Onwuemene, Chizoba I. Nnoruka, Christopher J. Patriquin, Laura S. Connelly‐Smith. Therapeutic plasma exchange in the management of immune checkpoint inhibitor‐associated immune‐related adverse effects: A review. Transfusion 2022; 62(11) doi: 10.1111/trf.17114
|
| 11 |
Dong-Sheng Fei, Xiao-Fei Bi, Jian-Nan Zhang, Yu-Jia Tang, Di Wu, Hui-Ying Liu, Huan Meng, Xiao-Hui Jiang, Jia Xu, Kuo Wang, Ying-Fei Zhi, Yang Gao, Kai Kang. Combined application of double plasma molecular adsorption system treatment, plasma exchange, and continuous veno-venous hemofiltration to rescue an adult patient with acute liver failure induced by accidental acute severe thinner intoxication: a case report. Journal of Medical Case Reports 2026; 20(1) doi: 10.1186/s13256-026-05871-w
|
| 12 |
Yan Lei, Yuling Liang, Xuemei Zhang, Xiaohua Wang, Yu Zhang, Yuk Ming Chan, Chun Tang, Zhihua Zheng. Alternating therapeutic plasma exchange (TPE) with double plasma molecular adsorption system (DPMAS) for the treatment of fulminant hepatic failure (FHF). Clinical Case Reports 2021; 9(12) doi: 10.1002/ccr3.5220
|
| 13 |
Ying Liu, Lihua Zheng, Wenxiong Xu, Qihuan Xu, Xinhua Li, Qu Lin, Lu Wang, Jing Lai. Efficacy of Plasma Exchange and a Double-Plasma Molecular Absorption System for Treating Immune Checkpoint Inhibitor-Related Hepatitis. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-137153
|